Role of Mutations in Epigenetic Regulators in Clonal Hematopoiesis and Evolution to AML

Apr 22, 2021 5:35pm ‐ Apr 22, 2021 6:00pm

Short Talk: Modelling Acquired Treatment Resistance in PDX ALL in vivo Reveals Identical Therapeutic Targets Regardless of Diverse Genomic Alterations

Apr 22, 2021 6:00pm ‐ Apr 22, 2021 6:15pm

Short Talk: SF3B1 Mutations Induce Oncogenic IRAK4 Isoforms and Activate Targetable Innate Immune Pathways in MDS and AML

Apr 22, 2021 6:15pm ‐ Apr 22, 2021 6:30pm

Short Talk: Dissect the Function of GPR68 in Acute Myeloid Leukemia and Hematopoietic Stem Cells

Apr 22, 2021 6:30pm ‐ Apr 22, 2021 6:45pm

Short Talk: Polybromo SWI/SNF Integrates Chromatin Remodeling & BMP/TGF-β Signaling to Determine Mesenchymal Stromal Osteolineage Commitment and Hematopoiesis

Apr 22, 2021 6:45pm ‐ Apr 22, 2021 7:00pm

Reprogramming B-ALL into APCs for Cancer Vaccination

Apr 23, 2021 9:00am ‐ Apr 23, 2021 9:25am

Hematologic Malignancies: Biology and Therapy

Apr 23, 2021 9:00am ‐ Apr 23, 2021 12:00pm

Differentiation Therapy in AML

Apr 23, 2021 9:25am ‐ Apr 23, 2021 9:50am

Innate Immune Deaminases Fuel Pre-Leukemia Stem Cell Malignant Transformation

Apr 23, 2021 9:50am ‐ Apr 23, 2021 10:15am

Coffee Break

Apr 23, 2021 10:15am ‐ Apr 23, 2021 10:30am